Effect of Pre-operative Exercise Training on Cardiorespiratory Fitness in Patients With Locally Advanced Non-small Cell Lung Cancer Undergoing Induction Chemo-immunotherapy Followed by Surgery - a Randomized Controlled Study
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Preoperative Exercise Training.
- Who it may be relevant to
- Registry conditions: Locally Advanced Non-small Cell Lung Cancer (NSCLC). Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Switzerland
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The PREHAB study focuses on patients with locally advanced non-small cell lung cancer (NSCLC) undergoing neoadjuvant chemotherapy and/or immunotherapy prior to surgical resection. These systemic treatments frequently impair patients' physiological reserve, reduce physical fitness, and may occasionally lead to cancellation of surgery. Surgery itself carries a substantial risk of cardiorespiratory complications and long-term functional decline. The primary objective of this study is to determine whether a supervised exercise program, initiated concomitantly with systemic therapy and continued until surgery, can improve cardiorespiratory fitness, surgical tolerance, and postoperative outcomes. A total of 74 patients will be randomly assigned to one of two groups: an "intervention" group participating in three weekly sessions of supervised endurance and resistance training for 12 to 16 weeks under the guidance of a physiotherapist, and a "control" group receiving usual care without a structured exercise program. The primary endpoint will be peak oxygen uptake (VO₂peak). Secondary outcomes will include postoperative complication rates, length of hospital stay, pulmonary function, skeletal muscle mass, and quality of life. Intervention-related risks, primarily falls or overexertion, will be mitigated through professional supervision. This multicenter study, with recruitment scheduled to begin in 2026, is expected to provide robust evidence regarding the effectiveness of targeted exercise training in improving preoperative fitness and postoperative recovery in patients with locally advanced NSCLC.
Detailed description
The PREHAB study is a prospective, multicenter, randomized controlled trial designed to evaluate the efficacy of a structured, supervised prehabilitation program in patients with locally advanced non-small cell lung cancer (NSCLC) undergoing neoadjuvant chemotherapy and/or immunotherapy prior to surgical resection.
Patients with stage III NSCLC increasingly receive multimodal treatment strategies combining systemic therapy followed by surgery. While neoadjuvant chemotherapy and immunotherapy have improved oncologic outcomes, these treatments frequently induce treatment-related deconditioning, sarcopenia, fatigue, and reduced cardiopulmonary reserve. Consequently, a subset of patients experiences functional decline significant enough to compromise surgical eligibility. Moreover, thoracic surgery itself is associated with substantial postoperative morbidity, particularly cardiorespiratory complications, and long-term impairment in physical performance.
The PREHAB trial is based on the hypothesis that early, structured, and supervised exercise training initiated concomitantly with systemic therapy and continued until surgery can mitigate treatment-induced physiological deterioration, preserve or enhance cardiorespiratory fitness, and ultimately improve perioperative and postoperative outcomes.
A total of 74 patients will be randomized in a 1:1 ratio to either:
* Intervention group: participation in a 12-16 week supervised exercise program consisting of three weekly sessions combining endurance and resistance training, delivered by trained physiotherapists. * Control group: standard oncologic care without a structured exercise intervention.
The primary endpoint is change in peak oxygen uptake (VO₂peak), measured by cardiopulmonary exercise testing, as an objective marker of cardiorespiratory fitness and surgical resilience.
Secondary endpoints include:
* Postoperative complication rates * Length of hospital stay * Pulmonary function parameters * Skeletal muscle mass * Health-related quality of life
Safety considerations focus primarily on the risk of falls and overexertion, both minimized through professional supervision and individualized exercise prescription.
By targeting the vulnerable neoadjuvant window - when patients are exposed to systemic therapy but have not yet undergone surgery - PREHAB aims to redefine perioperative optimization in locally advanced NSCLC. If positive, this trial could provide high-level evidence supporting the integration of structured exercise prehabilitation into standard multimodal lung cancer care pathways.
Interventions
- Procedure Preoperative Exercise Training
The intervention consists of a structured, supervised pre-operative exercise training program initiated concomitantly with induction chemo- and/or immunotherapy and continued until 24-72 hours prior to surgery. The program is delivered in an outpatient setting and supervised by trained physiotherapists following a standardized protocol across study sites. Participants randomized to the intervention group will complete three sessions per week, each lasting 45-60 minutes, for a total duration of
Primary outcome measures
- Change in peak oxygen uptake (VO₂peak) from baseline to pre-surgery [Time frame: From baseline to 24-72 hours prior to surgery at approximately 12-16 weeks.]
Secondary outcome measures (7)
- Change in ventilatory efficiency (VE/VCO₂ slope) from baseline to pre-surgery [Time frame: From baseline to 24-72 hours prior to surgery at approximately 12-16 weeks.]
- Change in 6-minute walk distance from baseline to pre-surgery [Time frame: From baseline to 24-72 hours prior to surgery at approximately 12-16 weeks.]
- Rate of 30-day postoperative cardiopulmonary complications [Time frame: From surgery to 30 days postoperatively.]
- Length of postoperative hospital stay [Time frame: From surgery until hospital discharge.]
- Change in health-related quality of life (EORTC QLQ-C30 global score) [Time frame: From baseline to 24-72 hours prior to surgery at approximately 12-16 weeks.]
- Change in skeletal muscle cross-sectional area on CT imaging [Time frame: From baseline to 4-6 weeks prior to surgery at approximately 12 weeks.]
- Change in pulmonary function (FEV1 and DLCO) from baseline to pre-surgery [Time frame: From baseline to 24-72 hours prior to surgery at approximately 12-16 weeks.]
Eligibility criteria
Inclusion criteria
- Age ≥18 years.
- Confirmed diagnosis of stage IIB, IIIA, IIIB or oligo-metastatic stage IV NSCLC.
- Planned induction therapy with either chemotherapy, immunotherapy or a combination of immuno-chemotherapy followed by an anatomical pulmonary resection.
- Absence of musculoskeletal conditions preventing safe physical exercise.
- Absence of any history of uncontrolled or unstable cardiac disease.
- Agreement to participate in the study by signing the study specific informed consent form.
Exclusion criteria
- Pregnancy (confirmed by a test if applicable).
- Induction therapy already initiated.
- Inability to walk independently.
- Lack of decision-making capacity.
- Oxygen-dependency before the initiation of the induction protocol.
- No capacity for discernment.
- Does not speak French.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Prevention
Study locations
Switzerland · 3 centers
- Hôpitaux Universitaires de Genève — Geneva
- Centre Hospitalier Universitaire Vaudois — Lausanne
- Hôpital de Sion — Sion
Identifiers
NCT: NCT07479407 · Preoperative exercise training